Skip to main content
All lobbying filings

REVVITY, INC.

Lobbying for REVVITY, INC.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $30,000.00 expenses · posted Oct 2, 2025

Official filing document

 Bills named in this filing 1
 Lobbying activity 2
Health Issues

Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs

Trade (domestic/foreign)

Medical Device & Pharmaceutical Adjacent Tariff

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem